axonopathy transport deficits early pathogenesis alzheimers disease 
identified axonal defects mouse models alzheimers disease preceded known disease-related pathology year observed similar axonal defects early stages alzheimers disease humans axonal defects consisted swellings accumulated abnormal amounts microtubule-associated molecular motor proteins organelles vesicles impairing axonal transport reducing dosage kinesin molecular motor protein enhanced frequency axonal defects increased amyloid-beta peptide levels amyloid deposition reductions microtubule-dependent transport may stimulate proteolytic processing beta-amyloid precursor protein resulting development senile plaques alzheimers disease 
